Antiemetic

This page covers all Antiemetic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nuclear receptor subfamily 1 group I member 3, Muscarinic acetylcholine receptor M4, Dopamine receptor.

Targets

Nuclear receptor subfamily 1 group I member 3 · Muscarinic acetylcholine receptor M4 · Dopamine receptor

Marketed (2)

• Antivert · Citron Pharma Llc · Other
• Cephadol · Neuroscience

Phase 3 pipeline (1)

• Prochlorperazine Injection · Newark Beth Israel Medical Center · Gastroenterology
  Prochlorperazine injection works by blocking dopamine receptors in the brain, which helps to reduce nausea and vomiting.